Source document or public record

FDA 510(k) K220763 — ALPCO Calprotectin Immunoturbidimetric Assay

FDA 510(k) index record K220763. Device: ALPCO Calprotectin Immunoturbidimetric Assay. Applicant as listed: ALPCO. Decision date: 2023-04-13.

OtherU.S. Food and Drug Administration (FDA)2023-04-13

Source

"device_name": "ALPCO Calprotectin Immunoturbidimetric Assay"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K220763.

Device name: ALPCO Calprotectin Immunoturbidimetric Assay. Applicant as listed: ALPCO.

Decision date: 2023-04-13. Decision wording: Substantially Equivalent.

Product code: NXO. Regulation: 21 CFR 866.5180. Medical specialty: Immunology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.